CLASS II Drug recall · Reported 22 Oct 2014 · FDA Enforcement Report

Hydroxyprogesterone Caproate 250 MG/ML (in Sesame Oil) recalled

Avella of Deer Valley is recalling Hydroxyprogesterone Caproate 250 MG/ML (in Sesame Oil), distributed nationwide in the US. The recall was initiated on 1 Oct 2014 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot# 12-20140207@109; Exp. 12/14 Lot# 12-20142107@82; Exp. 01/15
Quantity recalled197 vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0016-2014
FDA event ID
69405
Recalling firm
Avella of Deer Valley, Phoenix, AZ
Classification
Class II
Status
Terminated
Recall initiated
1 Oct 2014
FDA classified
10 Oct 2014
Reported
22 Oct 2014
Type
Voluntary: Firm initiated
Customers notified by
Telephone
Reason category
Other Reasons

Timeline

1 Oct 2014Recall initiated by company
10 Oct 2014Classified by FDA+9 days
22 Oct 2014Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Crystallization: Formation of crystals observed in product.

Product as listed by the FDA

HYDROXYPROGESTERONE CAPROATE 250 MG/ML (IN SESAME OIL), Rx Only 4 mL INJECTABLE IM USE. Manufactured by Avella Specialty Pharmacy, Phoenix, AZ 85085.

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Crystallization: Formation of crystals observed in product.

Which lots are affected?

Lot# 12-20140207@109; Exp. 12/14 Lot# 12-20142107@82; Exp. 01/15

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Avella of Deer Valley

All 3

Other Hydroxyprogesterone Caproate recalls

All 9